EGFR and colorectal carcinoma: Hence, we here investigated the therapeutic efficacy of an optimized nutritional intervention designed to inhibit increased aerobic glycolysis of tumor cells in the presence or absence of an EGFR-directed antibody-based therapy in a mouse model of colitis-driven CRC.